Georgia Tech announced Monday that nonprofit leader Susan G. Komen has awarded the university $450,000 to study immune responses and tumor immunity with regard to disease outcomes of breast cancer.
It’s one of 124 grants the nonprofit awarded totaling $3,800,000 in Georgia.
Komen as a whole donates heavily to early-career scientists and independent researchers. They organization uses money from the national network and from locally-raised funds. 25% of the funds go to research while 75% go to treatment and awareness programs for breast cancer in both men and women.
Dr. Judith A. Salerno, Komen’s president and CEO in a press release,“We cannot afford to lose talented scientists to other fields for lack of funding.”